This work was supported in part by a grant from the European Union's Seventh Framework Program (FP7/2007–2013) for the Innovative Medicine Initiative under grant agreement number IMI/115006 (the ...

Aspirin is effective for the prevention of cardiovascular events in patients with a history of vascular disease, as so-called secondary prevention. In general populations with no history of previous ...

Using aspirin could lower fibrosis indices among patients at risk of liver fibrosis, according to results from a new peer-reviewed study published in Alimentary Pharmacology & Therapeutics. Using ...

Please provide your email address to receive an email when new articles are posted on . Aspirin is the foundational treatment for secondary prevention of cardiac events and the standard therapy I have ...

The 1918 flu epidemic was probably the deadliest plague in human history, killing more than 50 million people worldwide. Now it appears that a small number of the deaths may have been caused not by ...

The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of ...

Anyone who takes medicines for cardiovascular disease, pain or chronic inflammation can justifiably feel indebted to John Vane, who was awarded a Nobel Prize in 1982 for unravelling the mode of action ...